期刊文献+

C-反应蛋白对新发非酒精性脂肪肝的预测价值 被引量:4

Predictive value of C-reactive protein in emerging non-alcoholic fatty liver disease
原文传递
导出
摘要 目的探讨C-反应蛋白(CRP)对新发非酒精性脂肪肝(NAFLD)的预测价值。方法采用前瞻性队列研究,以参加2006年7月至2007年10月健康体检的101510名某集团公司职工为研究对象,排除饮酒者、既往脂肪肝、心肌梗死、脑卒中、恶性肿瘤以及资料不全者,最终25843例纳入队列,将研究对象按基线CRP浓度分为三组,即CRP〈1mg/L组、CRP1~3mg/L组和CRP〉3mg/L组,比较各组新发NAFLD的检出率并采用多因素logistic回归模型分析各组NAFLD的发病风险。结果随着CRP浓度的增加,年龄、收缩压、舒张压、腰围、体质量指数、空腹血糖、总胆固醇、血尿酸水平、男性所占比例呈递增趋势护〈0.01)。CRP〈1mg/L组、CRP1~3mg/L组和CRP〉3mg/L组新发NAFLD检出率分别为24.6%、29.6%和30.6%(x2=92.10,P〈0.01)。logistic回归分析结果显示,在校正年龄、性别、腰围等混杂因素后,CRP1~3mg/L组和CRP〉3mg/L组发生NAFLD风险分别为CRP〈1mg/L组的1.09(95%可信区间1.01~1.17)和1.24(95%可信区间1.13~1.35)倍。结论CRP是NAFLD发病的独立预测因子。 Objective To investigate the predictive value of C-reactive protein (CRP) in emerging non- alcoholic fatty liver disease (NAFLD). Methods A prospective cohort study was performed. A total of 101510 employees of Kailuan Group Company who underwent physical examination from July 2006 to October 2007 were enrolled as study subjects. The employees with a history of drinking, fatty liver disease, myocardial infarction, stroke, and malignant tumors and incomplete data were excluded. Finally 25843 employees were enrolled in the cohort study. According to the baseline ClIP level, these employees were divided into CRP 〈 1 mg/L group, CRP 1-3 mg/L group, and CRP 〉 3 mg/L group. The detection rate of emerging NAFLD was compared between groups, and the multivariate logistic regression model was used to analyze the risk of NAFLD in each group. Results With the increasing CRP level, age, systolic pressure, diastolic pressure, waist circumference, body mass index, fasting blood glucose, total cholesterol, serum uric acid, and the proportion of male patients tended to increase (P 〈 0.01). The detection rate of emerging NAFLD was 24.6% in the CRP 〈 1 mg/L group, 29.6% in the CRP 1-3 mg/L group, and 30.6% in the CRP 〉 3 mg/L group (X2 = 92.10, P 〈 0.01 ). The results of the logistic regression analysis showed that after the confounding factors such as age, sex, and waist circumference were corrected, the risk of NAFLD in the CRP 1-3 mg/L group and CRP 〉 3 mg/L group was 1.09 (95% CI 1.01-1.17) and 1.24 (95% CI 1.13-1.35) times that in the CRP 〈 1 mg/L group. Conclusion CRP is the independent risk factor for the development of NAFLD
出处 《中华肝脏病杂志》 CAS CSCD 北大核心 2016年第8期575-579,共5页 Chinese Journal of Hepatology
关键词 C-反应蛋白 脂肪肝 非酒精性 预测因子 C-reactive protein Fatty liver, nonalcoholic Predictive factor
  • 相关文献

参考文献2

二级参考文献17

  • 1Wu, Sheng-Di,Wang, Ji-Yao,Li, Lei.Staging of liver fibrosis in chronic hepatitis B patients with a composite predictive model:A comparative study[J].World Journal of Gastroenterology,2010,16(4):501-507. 被引量:26
  • 2Fan, Jian-Gao,Peng, Yong-De.Metabolic syndrome and non-alcoholic fatty liver disease:Asian definitions and Asian studies[J].Hepatobiliary & Pancreatic Diseases International,2007,6(6):572-578. 被引量:42
  • 3范建高.糖尿病与肝病的关系及其诊治对策[J].中华糖尿病杂志,2009,1(4). 被引量:30
  • 4Sombat Treeprasertsuk,Einar Bjrnsson,Felicity Enders,Sompongse Suwanwalaikorn,Keith D Lindor.NAFLD fibrosis score:A prognostic predictor for mortality and liver complications among NAFLD patients[J].World Journal of Gastroenterology,2013,19(8):1219-1229. 被引量:13
  • 5Maitreyi Raman,Iftikhar Ahmed,Patrick M. Gillevet,Chris S. Probert,Norman M. Ratcliffe,Steve Smith,Rosemary Greenwood,Masoumeh Sikaroodi,Victor Lam,Pam Crotty,Jennifer Bailey,Robert P. Myers,Kevin P. Rioux.Fecal Microbiome and Volatile Organic Compound Metabolome in Obese Humans With Nonalcoholic Fatty Liver Disease[J].Clinical Gastroenterology and Hepatology.2013(7)
  • 6Edith M. Koehler,Jeoffrey N.L. Schouten,Bettina E. Hansen,Albert Hofman,Bruno H. Stricker,Harry L.A. Janssen.External Validation of the Fatty Liver Index for Identifying Nonalcoholic Fatty Liver Disease in a Population-based Study[J].Clinical Gastroenterology and Hepatology.2013
  • 7D. Festi,R. Schiumerini,L. Marzi,A. R. Di Biase,D. Mandolesi,L. Montrone,E. Scaioli,G. Bonato,G. Marchesini‐Reggiani,A. Colecchia.Review article: the diagnosis of non‐alcoholic fatty liver disease – availability and accuracy of non‐invasive methods[J].Aliment Pharmacol Ther.2012(4)
  • 8Victor de Lédinghen,Vincent Wai-Sun Wong,Julien Vergniol,Grace Lai-Hung Wong,Juliette Foucher,Shirley Ho-Ting Chu,Brigitte Le Bail,Paul Cheung-Lung Choi,Faiza Chermak,Karen Kar-Lum Yiu,Wassil Merrouche,Henry Lik-Yuen Chan.Diagnosis of liver fibrosis and cirrhosis using liver stiffness measurement: Comparison between M and XL probe of FibroScan?[J].Journal of Hepatology.2011(4)
  • 9MaitreyiRaman,Raylene A.Reimer.The potential role of prebiotic fibre for treatment and management of non‐alcoholic fatty liver disease and associated obesity and insulin resistance[J].Liver Int.2012(5)
  • 10Erin Marie McCarthy,Mary E. Rinella.The Role of Diet and Nutrient Composition in Nonalcoholic Fatty Liver Disease[J].Journal of the American Dietetic Association.2012(3)

共引文献1182

同被引文献23

引证文献4

二级引证文献45

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部